Share This

Public company info - CARsgen Therapeutics Holdings Limited , 02171.HK
Input the stock code or the company name     Search  
 
 Profile   Information   Data   Financial Ratios   Profit Loss   Cash Flow   Balance   Earnings   Dividend 

CARsgen Therapeutics Holdings Limited, 02171.HK - Cash Flow 2021-12 2020-12 2019-12
Net Cash Flow from Operating Activities -515,890 -295,913 -180,433
Net Cash Flow from Return on Investments & Servicing of Finance -1,882 -12,683 717
　Interest Received 8,803 763 1,429
　Interest Paid -10,685 -13,446 -712
　Dividend Received 0 0 0
　Dividend Paid 0 0 0
　Others 0 0 0
Taxes (Paid) / Refunded 0 0 0
Net Cash Flow from Investing Activities -2,476,556 -6,897 82,985
　Additions to Fixed Assets -175,841 -17,727 -102,641
　Disposal of Fixed Assets 11 0 0
　Increase in Investments 0 0 0
　Decrease in Investments 0 0 170,142
　Net Cash Flow with Related Parties 0 0 0
　Others -2,300,726 10,830 15,484
Net Cash Flow before Financing Activities -2,994,328 -315,493 -96,731
Net Cash Flow from Financing Activities 2,684,717 1,315,919 28,239
　New Loans 293,219 170,000 42,500
　Loans Repayment -162,944 -165,271 -256,386
　Fixed Income/Debt Instruments 0 0 0
　Repayment of Fixed Income/Debt Instruments 0 0 0
　Equity Financing 2,576,082 0 0
　Net Cash Flow with Related Parties 0 0 0
　Others -21,640 1,311,190 242,125
Increase(Decrease) in Cash & Cash Equivalents -309,611 1,000,426 -68,492
Cash & Cash Equivalents at Beginning of Year 1,042,969 96,476 163,553
Net Cash Flow due to Change in Exchange Rate/Others -42,074 -53,933 1,415
Cash & Cash Equivalents at End of Year 691,284 1,042,969 96,476
Currency Renminbi Renminbi Renminbi
Unit
Auditor's Opinion 1 0 0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.